Lisa Usdan
Endocrinology, Diabetes & Metabolism · Memphis, TNNPI 1053597674
Payments from drug & device makers
Across 2,865 payments — averaging $4985.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$10.2M
- GSK$1.3M
- Modernatx, Inc.$1M
- Novo Nordisk AS$724K
- Boehringer Ingelheim$282K
- Eli Lilly$186K
- plus $577K from 13 others
Across 8 payments — averaging $2794.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$13K
- Bausch Health US, LLC$10K
- Novo Nordisk AS$50
What the payments were for
- Consulting fees$70040%
- Speaking & faculty fees$35020%
- Food & beverage$61735%
- Education$764%
- Gifts$201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 705 | $10,234,151 |
| GSK | 235 | $1,254,388 |
| Modernatx, Inc. | 73 | $1,023,576 |
| Novo Nordisk AS | 785 | $724,384 |
| Boehringer Ingelheim | 33 | $282,100 |
| Eli Lilly | 7 | $186,445 |
| Novavax Inc | 40 | $180,571 |
| AbbVie | 63 | $168,510 |
| AstraZeneca | 7 | $81,993 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 3 | $45,600 |
| Alnylam Pharmaceuticals Inc. | 813 | $40,445 |
| Vertex | 2 | $36,390 |
| Boehringer Ingelheim International GmbH | 85 | $15,410 |
| Astrazeneca UK Limited | 4 | $4,382 |
| Merck | 1 | $3,000 |
| Novo Nordisk | 6 | $447 |
| Sequel Med Tech, LLC | 1 | $147 |
| Neurocrine Biosciences, Inc. | 1 | $87 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TWIIST$147
How this compares
$14,282,039 in reported general payments places this provider in the 95th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
See all endocrinology, diabetes & metabolism providers in Tennessee →
Other endocrinology, diabetes & metabolism in Memphis
- Pedro VelasquezMemphis$2.4M
- Alan CohenMemphis$1.5M
- Aidar GosmanovMemphis$833K
- Shimon HararyMemphis$735K
- Samuel Dagogo-JackMemphis$476K
- Ebenezer NyenweMemphis$438K
- Richard ChildressMemphis$212K
- Deirdre JamesMemphis$92K
- Malini GuptaMemphis$91K
- Benjamin BrannickMemphis$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.